Testing effectiveness (Phase 2)Study completedNCT04640402
What this trial is testing
A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)
Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 960